Keyphrases
Spinal Cord Injury
100%
Pathway Modulation
100%
Cell Cycle Pathway
100%
Flavopiridol
60%
Functional Recovery
40%
Cell Cycle Proteins
40%
Cell Cycle Inhibitors
40%
Iba1
40%
Clinically Significant
20%
Pathophysiology
20%
Cyclin-dependent Kinase
20%
Therapeutic Potential
20%
Systemic Administration
20%
E2F Transcription Factor 1 (E2F1)
20%
Biochemical Response
20%
Treatment Initiation
20%
Secondary Injury
20%
Microglia
20%
Pathway Activation
20%
Microglial Activation
20%
Oligodendrocyte
20%
Cyclin-dependent Kinase 4 (CDK4)
20%
Cause of Injury
20%
Gene Knockout
20%
Study Support
20%
Treatment Model
20%
Neurological Dysfunction
20%
Physiological Response
20%
Spinal Cord Compression
20%
Tissue Loss
20%
Inhibitor Treatment
20%
OR Genes
20%
Myelinated
20%
Human Spinal Cord Injury
20%
Intrathecal
20%
Immunoblot Analysis
20%
Cyclin D1 (CCND1)
20%
Traumatic Spinal Cord Injury
20%
Lesion Volume
20%
Cyclin-dependent Kinase Inhibitor p27
20%
Injured Spinal Cord
20%
Cell Cycle Activation
20%
Point Following
20%
P27 Expression
20%
Mechanical Damage
20%
Contusion Model
20%
Rat Spinal Cord Injury
20%
Spared White Matter
20%
CHL1
20%
Astrocytic Reactivity
20%
Neuroscience
Cell Cycle
100%
Spinal Cord Injury
100%
Intrathecal
12%
Traumatic Spinal Cord Injury
12%
E2F1
12%
Histopathology
12%
Cyclin-Dependent Kinase
12%
Cyclin D1
12%
Cyclin Dependent Kinase Inhibitor 1B
12%
Cell Cycle Protein
12%
Microglia
12%
Oligodendrocyte
12%
Gene Knockout
12%
Immunoblotting
12%
Immunology and Microbiology
Spinal Cord
100%
Cell Cycle
100%
Cycline
20%
Microglia
10%
Western Blot
10%
down Regulation
10%
Upregulation
10%
Cyclin D1
10%
White Matter
10%
Lesion Volume
10%
Gene Targeting
10%
Gene Knockout
10%
Pharmacology, Toxicology and Pharmaceutical Science
Spinal Cord Injury
100%
Flavopiridol
33%
Contusion
22%
Western Blot
11%
Injury
11%
Systemic Administration
11%
Intrathecal
11%
Cyclin Dependent Kinase
11%
Cyclin D1
11%
Cyclin Dependent Kinase Inhibitor 1B
11%
Cell Cycle Protein
11%
Pathophysiology
11%